Skip to Main Content

Paper Details

Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC).
Mol Imaging Biol
1
2019
Author NameAffiliation
Peggy L PorterClinical Research Division, Fred Hutchinson Cancer Research Center
  • 1 - 1

Datasets

Release 1.2